Personalized Clinical Approaches to Anxiety Disorders

被引：7
|
作者：
Perna, Giampaolo [1 ,2 ]
Alciati, Alessandra [2 ,3 ]
Sangiorgio, Erika [1 ,2 ]
Caldirola, Daniela [1 ,2 ]
Nemeroff, Charles B. [4 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[2] Villa San Benedetto Menni Hosp, Hermanas Hosp, Dept Clin Neurosci, Como, Italy
[3] Humanitas Clin & Res Ctr, Milan, Italy
[4] Univ Texas Austin, Dell Med Sch Austin, Inst Early Life Advers Res, Austin, TX 78712 USA
来源：
ANXIETY DISORDERS: RETHINKING AND UNDERSTANDING RECENT DISCOVERIES | 2020年 / 1191卷
关键词：
CARBON-DIOXIDE HYPERSENSITIVITY; COGNITIVE-BEHAVIORAL THERAPY; NOREPINEPHRINE TRANSPORTER GENE; 35-PERCENT CO2 HYPERREACTIVITY; OBSESSIVE-COMPULSIVE DISORDER; RANDOMIZED CONTROLLED-TRIAL; BDNF VAL66MET POLYMORPHISM; GENERALIZED SOCIAL PHOBIA; CHINESE HAN POPULATION; HEART-RATE-VARIABILITY;
D O I：
10.1007/978-981-32-9705-0_25
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：489 / 521
页数：33
相关论文
共 50 条
  • [21] Towards new approaches to disorders of fear and anxiety
    Dias, Brian G.
    Banerjee, Sunayana B.
    Goodman, Jared V.
    Ressler, Kerry J.
    CURRENT OPINION IN NEUROBIOLOGY, 2013, 23 (03) : 346 - 352
  • [22] Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
    Sheehan, David V.
    Sheehan, Kathy Harnett
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (01) : 98 - 109
  • [23] Innovative Approaches in Clinical Anxiety Assessment
    Helbig-Lang, Sylvia
    Petermann, Franz
    VERHALTENSTHERAPIE, 2009, 19 (03) : 145 - 151
  • [24] Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers
    Zastrozhin, Michael S.
    Sorokin, Aleksandr S.
    Agibalova, Tatyana V.
    Grishina, Elena A.
    Antonenko, Anastasiya P.
    Rozochkin, Ilya N.
    Duzhev, Denis V.
    Skryabin, Valentine Y.
    Galaktionova, Tatyana E.
    Barna, Ilya V.
    Orlova, Anna V.
    Aguzarov, Albert D.
    Savchenko, Ludmila M.
    Bryun, Evgeny A.
    Sychev, Dmitry A.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2018, 33 (06)
  • [25] Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico
    Rios, Flor Cristina Ortiz
    Ruiz, Itzel Guadalupe Davila
    Dumani, Elisa Sacal
    DRUGS IN CONTEXT, 2022, 11
  • [26] ANXIETY DISORDERS - CLINICAL AND NEUROBIOLOGICAL ASPECTS
    Lahousen, Theresa
    Kapfhammer, Hans-Peter
    PSYCHIATRIA DANUBINA, 2018, 30 (04) : 479 - 490
  • [27] Anxiety disorders in adults: A clinical guide
    Brittlebank, A
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 592 - 593
  • [28] DIAGNOSTIC AND CLINICAL ISSUES AND ANXIETY DISORDERS
    LOPEZIBOR, JJ
    MASSANA, J
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 : 142 - 143
  • [29] Clinical perspective of Anxiety Disorders in Korea
    Stein, Dan
    Oh, Kang-Seob
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 23 - 23
  • [30] Clinical pathways for mood and anxiety disorders
    IsHak, WW
    CNS SPECTRUMS, 2004, 9 (12) : 18 - 24
12345